Correlation Between NRx Pharmaceuticals and EFFECTOR Therapeutics
Can any of the company-specific risk be diversified away by investing in both NRx Pharmaceuticals and EFFECTOR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRx Pharmaceuticals and EFFECTOR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRx Pharmaceuticals and EFFECTOR Therapeutics, you can compare the effects of market volatilities on NRx Pharmaceuticals and EFFECTOR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRx Pharmaceuticals with a short position of EFFECTOR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRx Pharmaceuticals and EFFECTOR Therapeutics.
Diversification Opportunities for NRx Pharmaceuticals and EFFECTOR Therapeutics
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between NRx and EFFECTOR is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding NRx Pharmaceuticals and EFFECTOR Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EFFECTOR Therapeutics and NRx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRx Pharmaceuticals are associated (or correlated) with EFFECTOR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EFFECTOR Therapeutics has no effect on the direction of NRx Pharmaceuticals i.e., NRx Pharmaceuticals and EFFECTOR Therapeutics go up and down completely randomly.
Pair Corralation between NRx Pharmaceuticals and EFFECTOR Therapeutics
If you would invest 5.50 in NRx Pharmaceuticals on August 29, 2024 and sell it today you would lose (0.21) from holding NRx Pharmaceuticals or give up 3.82% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 5.0% |
| Values | Daily Returns |
NRx Pharmaceuticals vs. EFFECTOR Therapeutics
Performance |
| Timeline |
| NRx Pharmaceuticals |
| EFFECTOR Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
NRx Pharmaceuticals and EFFECTOR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NRx Pharmaceuticals and EFFECTOR Therapeutics
The main advantage of trading using opposite NRx Pharmaceuticals and EFFECTOR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRx Pharmaceuticals position performs unexpectedly, EFFECTOR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EFFECTOR Therapeutics will offset losses from the drop in EFFECTOR Therapeutics' long position.| NRx Pharmaceuticals vs. NRX Pharmaceuticals | NRx Pharmaceuticals vs. Relief Therapeutics Holding | NRx Pharmaceuticals vs. Quantum Si incorporated | NRx Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
| EFFECTOR Therapeutics vs. Celularity | EFFECTOR Therapeutics vs. Humacyte | EFFECTOR Therapeutics vs. NRx Pharmaceuticals | EFFECTOR Therapeutics vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |